Literature DB >> 21542015

Uric acid as a potential disease modifier in patients with multiple system atrophy.

Ji E Lee1, Sook K Song, Young H Sohn, Phil Hyu Lee.   

Abstract

BACKGROUND: Recent studies have suggested that mitochondrial dysfunction and oxidative stress play a key role in the pathogenesis of multiple system atrophy.
METHODS: We evaluated the influence of serum uric acid levels on disease progression in 52 patients with multiple system atrophy using changes in the annualized Unified Multiple System Atrophy Rating Scale scores.
RESULTS: The mean annualized Unified Multiple System Atrophy Rating Scale changes were significantly lower in patients with the highest uric acid quartile compared with those with the lowest quartile (8.4 ± 5.1 vs 20.2 ± 16.0, P = .038). Serum uric acid levels had a significant negative correlation with the annualized Unified Multiple System Atrophy Rating Scale changes (r = -0.40, P = .004). Multiple linear regression analysis showed that only serum uric acid concentration was significantly correlated with the annualized Unified Multiple System Atrophy Rating Scale changes (β = -2.687, P = .011).
CONCLUSIONS: These data suggest that serum uric acid may act as a potential disease modifier in multiple system atrophy.
Copyright © 2010 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21542015     DOI: 10.1002/mds.23556

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  13 in total

1.  Uric acid is associated with the prevalence but not disease progression of multiple system atrophy in Chinese population.

Authors:  Bei Cao; Xiaoyan Guo; Ke Chen; Wei Song; Rui Huang; Qian-Qian Wei; Bi Zhao; Hui-Fang Shang
Journal:  J Neurol       Date:  2013-06-26       Impact factor: 4.849

Review 2.  Diagnostic utility of fluid biomarkers in multiple system atrophy: a systematic review and meta-analysis.

Authors:  Shengri Cong; Chunchen Xiang; Hailong Wang; Shuyan Cong
Journal:  J Neurol       Date:  2020-03-11       Impact factor: 4.849

Review 3.  Urate as a Marker of Risk and Progression of Neurodegenerative Disease.

Authors:  Sabrina Paganoni; Michael A Schwarzschild
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

4.  Uric acid levels predict survival in men with amyotrophic lateral sclerosis.

Authors:  Sabrina Paganoni; May Zhang; Alejandro Quiroz Zárate; Matthew Jaffa; Hong Yu; Merit E Cudkowicz; Anne-Marie Wills
Journal:  J Neurol       Date:  2012-02-10       Impact factor: 4.849

5.  Serum uric acid level is associated with the prevalence but not with survival of amyotrophic lateral sclerosis in a Chinese population.

Authors:  Zhenzhen Zheng; Xiaoyan Guo; Qianqian Wei; Wei Song; Bei Cao; Rui Huang; Ruwei Ou; Xueping Chen; Huifang Shang
Journal:  Metab Brain Dis       Date:  2014-03-01       Impact factor: 3.584

6.  Serum urate at trial entry and ALS progression in EMPOWER.

Authors:  ÉIlis J O'Reilly; Dawei Liu; Donald R Johns; Merit E Cudkowicz; Sabrina Paganoni; Michael A Schwarzschild; Melanie Leitner; Alberto Ascherio
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2016-09-28       Impact factor: 4.092

7.  Postmortem brain levels of urate and precursors in Parkinson's disease and related disorders.

Authors:  Nikolaus R McFarland; Thomas Burdett; Cody A Desjardins; Matthew P Frosch; Michael A Schwarzschild
Journal:  Neurodegener Dis       Date:  2013-02-28       Impact factor: 2.977

8.  Influence of serum uric acid levels on prognosis and survival in amyotrophic lateral sclerosis: a meta-analysis.

Authors:  Alon Abraham; Vivian E Drory
Journal:  J Neurol       Date:  2014-04-04       Impact factor: 4.849

9.  Level of uric acid and uric acid/creatinine ratios in correlation with stage of Parkinson disease.

Authors:  Ling-Ling Zhong; Ya-Qi Song; Xiang-Yang Tian; Hua Cao; Ke-Ju Ju
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

10.  Cerebrospinal fluid biomarker candidates for parkinsonian disorders.

Authors:  Radu Constantinescu; Stefania Mondello
Journal:  Front Neurol       Date:  2013-01-21       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.